Supplementary Figure S1. Association between LDL‐C and ASCVD risk (including those on lipid‐lowering therapy).

Supplementary Table S1. Distribution of deaths by deciles of LDL‐C and the ratio of noncardiovascular to cardiovascular deaths.

Supplementary Table S2. Kaplan‐Meier estimates and cumulative incidence estimates by decile of LDL‐C.

Supplementary Table S3. Baseline characteristics by number of risk factors.

Supplementary Table S4. The 5‐year ASCVD risk among ≥75‐year‐old patients with zero, one, or two risk factors, with and without hyperlipidemia, with patients on lipid‐lowering therapy excluded.